GoldmanSachs International Form 38.5b (6243G)
23 Novembro 2015 - 9:55AM
UK Regulatory
TIDMPFZ
RNS Number : 6243G
GoldmanSachs International
23 November 2015
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT,
1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal (GS) GOLDMAN SACHS
trader INTERNATIONAL
======================== ==================
Company dealt in PFIZER INC
======================== ==================
Class of relevant USD ordinary & GDR
security to which
the dealings being
disclosed relate
(Note 1)
======================== ==================
Date of dealing 20 November 2015
======================== ==================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security dealt in (Note 2)
Long Short
=========================== ================= ===================
Number (%) Number (%)
=========================== ======= ======== =========== ======
1,346,803
(1) Relevant securities (0.02) 43,798 (0.00)
=========================== ================= ===================
(2) Derivatives (other
than options) 0 (0.00) 0 (0.00)
=========================== ================= ===================
(3) Options and agreements
to purchase/sell 0 (0.00) 0 (0.00)
=========================== ================= ===================
1,346,803
Total (0.02) 43,798 (0.00)
=========================== ================= ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 2)
Class of relevant Long Short
security:
========================== =================== =====================
Number (%) Number (%)
========================== ========= ====== =========== ======
(1) Relevant securities
========================== =================== =====================
(2) Derivatives (other
than options)
========================== =================== =====================
(3) Options and agreements
to purchase/sell
========================== =================== =====================
Total
========================== =================== =====================
Ap28
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of relevant Price per
securities unit (Note
4)
================= ========================= ================
Purchase (Borrow 871,504 N/A
New)
================= ========================= ================
Sale (Borrow 94,000 N/A
Partial Return)
================= ========================= ================
Sale (Borrow 814,499 N/A
Full Return)
================= ========================= ================
Purchase (Borrow 929 N/A
Adjust)
================= ========================= ================
Purchase (Borrow 1,314 N/A
Adjust)
================= ========================= ================
Purchase (Borrow 674 N/A
Adjust)
================= ========================= ================
Purchase (Borrow 432 N/A
Adjust)
================= ========================= ================
Sale (Borrow 929 N/A
Partial Return)
================= ========================= ================
Sale (Borrow 1,314 N/A
Partial Return)
================= ========================= ================
Sale (Borrow 675 N/A
Partial Return)
================= ========================= ================
Sale (Borrow 432 N/A
Partial Return)
================= ========================= ================
Purchase (Borrow 57,005 N/A
New)
================= ========================= ================
Sale (Borrow 57,005 N/A
Full Return)
================= ========================= ================
(b) Derivatives transactions (other than options transactions)
Product Nature of Number of relevant Price
name, transaction securities per unit
e.g. CFD (Note 5) (Note 6) (Note
4)
========== ============= =================== ==========
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number Exercise Type, Expiry Option
name, selling, of securities price e.g. date money
e.g. purchasing, to which American, paid/received
call varying the option European per unit
option etc. relates etc. (Note
(Note 4)
7)
======== ============= =============== ========= =========== ====== ===============
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call per unit (Note
option 4)
============== =========================== ====================
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Nature of Details Price per
transaction unit
(Note 7) (if applicable)
(Note 4)
============= ============== =====================
Ap29
OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities
under any option referred to on this form or relating to the
voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced.
If none, this should be stated.
Is a Supplemental Form 38.5(b) attached? (Note 8) YES/NO
Date of disclosure 23 November 2015
======================== ====================
Contact name Aadithya Rao and
Yiannis Bardis
======================== ====================
+44(20) 7051 9046
Telephone number / +44(20) 7774 7107
======================== ====================
Name of offeree/offeror Pfizer Inc
with which connected
======================== ====================
Nature of connection Advisor to Offeror
(Note 9)
======================== ====================
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEEAFFDASLSFFF
(END) Dow Jones Newswires
November 23, 2015 06:55 ET (11:55 GMT)
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
